Clementia Pharmaceuticals Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Clementia Pharmaceuticals Inc. - overview
Established
2011
Location
Montreal, QC, Canada
Primary Industry
Pharmaceuticals
About
Founded in 2011 and based in Montreal, Quebec, Clementia Pharmaceuticals Inc. is a biopharmaceutical company that develops treatments for patients suffering from ultra-rare bone disorders and other diseases. They are developing palovarotene, an investigational retinoic acid receptor gamma (RAR? ) selective agonist, for the treatment of individuals with fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas (MO) and dry eye disease.
Current Investors
Fonds de solidarité FTQ Investissements, OrbiMed Advisors, BDC Capital
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Epidemiology, Pharmaceutical Research & Development
Website
www.clementiapharma.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.